Host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Flaxel and Dr. Rudnick about how a home monitoring device could ...

COMO (NCT07449936) and CAPRI (NCT07449923), the two global Phase 3 trials of EYP-1901 vorolanib intravitreal insert (DURAVYU) ...

Since I started offering robotic laser cataract surgery, I have always been straightforward with patients, but it surprised me how much they lit up when they heard me say during a surgical ...

Noha Ekdawi, MD, FAAP, explains why pediatric myopia demands individualized, progression-based management—detailing how they sequence spectacle defocus lenses, low-dose atropine, and specialty ...

Wnt pathway modulation, sustained-release TKI delivery, and topical steroid dosing are advancing through phase 3 trials in DME, testing approaches distinct from standard anti-VEGF injections.

Robin A. Vora, MD, a retina specialist at Kaiser Permanente Oakland Medical Center, told Modern Retina that misdiagnosis of ...

Artelo Biosciences has enrolled the first patient in the phase 2 DREAM study, evaluating the company’s orally administered ...

Sight Sciences' newest MIGS device gains FDA clearance for single-pass canaloplasty and trabeculotomy in open-angle glaucoma.

A high-fat diet contributes to development of obesity, glucose intolerance, insulin resistance, and chronic inflammation. Evidence suggests that the negative effects may also reach the central nervous ...

The FDA has granted Priority Review to Belite Bio's NDA for tinlarebant in Stargardt disease type 1, positioning it as a ...

Ahead of his November 10, 2026, start date, the incoming Duke ophthalmology chair shares his vision for research, training, and the integration of AI and data science. As academic medical centers ...